Major Chinese Ethnic Medicines for Prevention and Treatment of Ischemic Heart Diseases： A Review
10.13422/j.cnki.syfjx.20220355
- VernacularTitle:我国主要少数民族医药防治缺血性心脏病研究概述
- Author:
Jixuan XU
1
;
Xiaojing MA
1
;
Hongying CHEN
1
;
Xiaoli GAO
1
;
Haiying TONG
1
;
Pengfei TU
1
;
Chao AN
2
;
Xingyun CHAI
1
Author Information
1. Beijing Research Institute of Chinese Medicine，School of Traditional Chinese Medicine， Beijing University of Chinese Medicine，Beijing 100029，China
2. Dongfang Hospital，Beijing University of Chinese Medicine，Beijing 100078，China
- Publication Type:Journal Article
- Keywords:
ethnic medicine;
ischemic heart disease;
Tibetan medicine;
Mongolian medicine;
Dai medicine;
basic research;
clinical research
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2022;28(17):235-247
- CountryChina
- Language:Chinese
-
Abstract:
In China， the incidence of ischemic heart disease （IHD） is increasing year by year， which brings enormous burden to families and society. It is urgent to find preferable treatment methods and medical therapies. The Chinese ethnic minority medicine has gradually developed unique theoretical systems and therapeutic characteristics on the basis of clinical experience and thinking modes including image-number thinking and the holistic perspective. Consequently， it possesses huge application capacity and research value in prevention and treatment of IHD. Belonging to the medical system based on the view of nature and life， the Tibetan medicine， Mongolian medicine， and Dai medicine have respectively formed theories like "three elements" "three life-sustaining energies" "four elements and five skandhas （aggregates）" ， have put forward unique understandings of IHD and have formed corresponding therapeutic principles and methods， generating plentiful classic prescriptions represented by Sanwei Tanxiang powder， Bawei Chenxiang powder， Roukou Wuwei pills and Yajiao Hadun powder. They also contain characteristic ethnic medicine resources such as Choerospondiatis Fructus， Rhodiola Rosea and Draconis Sanguis. Aiming to provide enlightenment and reference for the clinical application and development of the Chinese ethnic minority medicine for the prevention and treatment of IHD， the authors try to summarize the related researches represented by Tibetan and Mongolian medicines， and then discuss the opportunities and challenges faced by such researches.
